Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area

Affiliations

¹ Sorbonne Université, AP-HP, DMU3ID, Tenon hospital, Internal medicine department, national reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), Paris, France.
² General pediatry department, Versaille hospital, André-Mignot, General pediatry department, National reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), versailles, France.
³ Department of Internal Medicine, Hopital Foch, Sursennes, France.
⁴ Sorbonne Université, AP-HP, DMU3ID, Tenon hospital, Internal medicine department, national reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), Paris, France sophie.georgin-lavialle@aphp.fr.

^# Contributed equally.

Rim Bourguiba et al. Ann Rheum Dis. 2021 Apr.

. 2021 Apr;80(4):539-540.

doi: 10.1136/annrheumdis-2020-218707. Epub 2020 Nov 2.

¹ Sorbonne Université, AP-HP, DMU3ID, Tenon hospital, Internal medicine department, national reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), Paris, France.
² General pediatry department, Versaille hospital, André-Mignot, General pediatry department, National reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), versailles, France.
³ Department of Internal Medicine, Hopital Foch, Sursennes, France.
⁴ Sorbonne Université, AP-HP, DMU3ID, Tenon hospital, Internal medicine department, national reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), Paris, France sophie.georgin-lavialle@aphp.fr.

^# Contributed equally.

No abstract available

Keywords: amyloidosis; familial Mediterranean fever; inflammation.

Conflict of interest statement

Competing interests: None declared.